Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats.
Gostelow R, Hazuchova K.
Vet Clin North Am Small Anim Pract. 2023 May;53(3):511-529. doi: 10.1016/j.cvsm.2023.02.001. Epub 2023 Mar 8.
Acromegaly pathogenesis and treatment.
Melmed S.
J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2.
Acromegaly is associated with high fibroblast growth factor-21 levels.
Yurekli BS, Kutbay NO, Aksit M, Suner A, Simsir IY, Seckiner S, Kocabas GU, Bozkaya G, Saygili F.
J Endocrinol Invest. 2019 Jan;42(1):53-60. doi: 10.1007/s40618-018-0885-1. Epub 2018 May 12.
Insulin Resistance in Patients With Acromegaly.
Vila G, Jørgensen JOL, Luger A, Stalla GK.
Front Endocrinol (Lausanne). 2019 Jul 30;10:509. doi: 10.3389/fendo.2019.00509. eCollection 2019.
Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H, Takahashi Y, Iida K, Kudo T, Nishizawa H, Imanaka M, Takeno R, Iguchi G, Takahashi K, Okimura Y, Kaji H, Chihara K.
Horm Res. 2008;69(3):165-71. doi: 10.1159/000112590. Epub 2008 Jan 8.
Diabetes in Patients With Acromegaly.
Hannon AM, Thompson CJ, Sherlock M.
Curr Diab Rep. 2017 Feb;17(2):8. doi: 10.1007/s11892-017-0838-7.
Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved.
Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K, Yamada S, Takeuchi Y.
Eur J Endocrinol. 2011 Apr;164(4):467-73. doi: 10.1530/EJE-10-1096. Epub 2011 Feb 1.
Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.
Rosario PW.
Pituitary. 2011 Sep;14(3):217-21. doi: 10.1007/s11102-010-0281-0.
Increased glycated albumin levels in patients with acromegaly related to glucose fluctuation caused by growth hormone excess but not albumin metabolism.
Taguchi T, Suzuki A, Takano K.
Endocr J. 2022 Mar 28;69(3):225-233. doi: 10.1507/endocrj.EJ21-0439. Epub 2021 Sep 28.
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant.
Drake WM, Rowles SV, Roberts ME, Fode FK, Besser GM, Monson JP, Trainer PJ.
Eur J Endocrinol. 2003 Dec;149(6):521-7. doi: 10.1530/eje.0.1490521.
